| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF134 ZNF627 ZEB1 ZSCAN5DP MAZ ZNF280C ZNF202 ZNF322 ZKSCAN2 ZNF280B MYNN ZBTB26 MEIS3 ZNF112 ZNF236 ADNP ZNF529 GFI1 ZNF568 MEIS2 ZFY ZNF599 ZBTB46 ZNF836 ZNF846 SKOR1 ZBTB10 NFXL1 ZNF888 ZNF770 ZSCAN2 ZNF841 ZNF543 ZNF583 ZNF443 ZNF292 NPAS2 | 2.33e-17 | 1412 | 103 | 37 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF567 ZNF134 ZNF627 ZEB1 ZSCAN5DP MAZ ZNF280C ZNF202 ZNF322 ZKSCAN2 ZNF280B MYNN ZBTB26 MEIS3 ZNF112 ZNF236 ADNP ZNF529 GFI1 ZNF568 MEIS2 ZFY ZNF710 ZNF599 ZNF836 ZNF846 SKOR1 ZBTB10 NFXL1 ZNF888 ZNF770 ZSCAN2 ZNF841 ZNF543 ZNF583 ZNF443 NPAS2 | 6.76e-17 | 1459 | 103 | 37 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF567 ZNF134 ZEB1 ZSCAN5DP MAZ ZNF280C ZNF202 ZNF322 ZKSCAN2 ZNF280B MYNN ZBTB26 MEIS3 ZNF112 ZNF236 GFI1 ZNF568 MEIS2 ZFY ZNF710 ZNF836 SKOR1 ZNF888 ZNF770 ZSCAN2 ZNF841 ZNF543 ZNF583 NPAS2 | 3.07e-12 | 1244 | 103 | 29 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF567 ZNF134 ZEB1 ZSCAN5DP MAZ ZNF280C ZNF202 ZNF322 ZKSCAN2 ZNF280B MYNN ZBTB26 MEIS3 ZNF112 ZNF236 GFI1 ZNF568 MEIS2 ZFY ZNF710 ZNF836 SKOR1 ZNF888 ZNF770 ZSCAN2 ZNF841 ZNF543 ZNF583 NPAS2 | 5.20e-12 | 1271 | 103 | 29 | GO:0000987 |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 1.33e-07 | 3 | 103 | 3 | GO:0005220 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 4.66e-05 | 14 | 103 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.03e-04 | 18 | 103 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 2.53e-04 | 320 | 103 | 8 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 2.87e-04 | 326 | 103 | 8 | GO:0001217 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 5.39e-04 | 31 | 103 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 6.50e-04 | 33 | 103 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 9.12e-04 | 37 | 103 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | pore-forming activity | 1.15e-03 | 10 | 103 | 2 | GO:0140911 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 1.01e-05 | 9 | 105 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.97e-05 | 11 | 105 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | Golgi lumen | 2.24e-04 | 109 | 105 | 5 | GO:0005796 | |
| Domain | ZINC_FINGER_C2H2_1 | CBLL1 ZNF567 ZNF134 ZNF627 TUT4 ZEB1 ZSCAN5DP MAZ ZNF280C ZNF202 ZNF322 ZNF233 ZKSCAN2 ZNF280B MYNN ZBTB26 ZNF112 ZNF236 ADNP ZNF529 GFI1 ZNF568 ZFY ZNF710 ZNF462 ZNF599 ZBTB46 ZNF836 ZNF846 ZFP64 ZBTB10 ZNF770 ZSCAN2 ZNF841 ZNF543 ZNF583 ZNF443 ZNF292 | 2.46e-26 | 777 | 103 | 38 | PS00028 |
| Domain | Znf_C2H2-like | CBLL1 ZNF567 ZNF134 ZNF627 ZEB1 ZSCAN5DP MAZ ZNF280C ZNF202 ZNF322 ZNF233 ZKSCAN2 ZNF280B MYNN ZBTB26 ZNF112 ZNF236 ADNP ZNF529 GFI1 ZNF568 ZFY ZNF710 ZNF462 ZNF599 ZBTB46 ZNF836 ZNF846 ZFP64 ZBTB10 ZNF770 ZSCAN2 ZNF841 ZNF543 ZNF583 SF3A2 ZNF443 ZNF292 | 5.89e-26 | 796 | 103 | 38 | IPR015880 |
| Domain | ZnF_C2H2 | CBLL1 ZNF567 ZNF134 ZNF627 ZEB1 ZSCAN5DP MAZ ZNF280C ZNF202 ZNF322 ZNF233 ZKSCAN2 ZNF280B MYNN ZBTB26 ZNF112 ZNF236 ADNP ZNF529 GFI1 ZNF568 ZFY ZNF710 ZNF462 ZNF599 ZBTB46 ZNF836 ZNF846 ZFP64 ZBTB10 ZNF770 ZSCAN2 ZNF841 ZNF543 ZNF583 SF3A2 ZNF443 ZNF292 | 1.01e-25 | 808 | 103 | 38 | SM00355 |
| Domain | ZINC_FINGER_C2H2_2 | CBLL1 ZNF567 ZNF134 ZNF627 ZEB1 ZSCAN5DP MAZ ZNF280C ZNF202 ZNF322 ZNF233 ZKSCAN2 ZNF280B MYNN ZBTB26 ZNF112 ZNF236 ADNP ZNF529 GFI1 ZNF568 ZFY ZNF710 ZNF462 ZNF599 ZBTB46 ZNF836 ZNF846 ZFP64 ZBTB10 ZNF770 ZSCAN2 ZNF841 ZNF543 ZNF583 ZNF443 ZNF292 | 3.13e-25 | 775 | 103 | 37 | PS50157 |
| Domain | Znf_C2H2 | ZNF567 ZNF134 ZNF627 ZEB1 ZSCAN5DP MAZ ZNF280C ZNF202 ZNF322 ZNF233 ZKSCAN2 ZNF280B MYNN ZBTB26 ZNF112 ZNF236 ADNP ZNF529 GFI1 ZNF568 ZFY ZNF710 ZNF462 ZNF599 ZBTB46 ZNF836 ZNF846 ZFP64 ZBTB10 ZNF770 ZSCAN2 ZNF841 ZNF543 ZNF583 SF3A2 ZNF443 ZNF292 | 1.18e-24 | 805 | 103 | 37 | IPR007087 |
| Domain | Znf_C2H2/integrase_DNA-bd | CBLL1 ZNF567 ZNF134 ZNF627 ZEB1 ZSCAN5DP MAZ ZNF202 ZNF322 ZNF233 ZKSCAN2 MYNN ZBTB26 ZNF112 ZNF236 ADNP ZNF529 GFI1 ZNF568 ZFY ZNF710 ZNF462 ZNF599 ZBTB46 ZNF836 ZNF846 ZFP64 ZBTB10 ZNF770 ZSCAN2 ZNF841 ZNF543 ZNF583 ZNF443 ZNF292 | 1.38e-24 | 694 | 103 | 35 | IPR013087 |
| Domain | - | CBLL1 ZNF567 ZNF134 ZNF627 ZEB1 MAZ ZNF202 ZNF322 ZNF233 ZKSCAN2 MYNN ZBTB26 ZNF112 ZNF236 ZNF529 GFI1 ZNF568 ZFY ZNF710 ZNF462 ZNF599 ZBTB46 ZNF836 ZNF846 ZFP64 ZBTB10 ZNF770 ZSCAN2 ZNF841 ZNF543 ZNF583 ZNF443 ZNF292 | 1.28e-22 | 679 | 103 | 33 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF567 ZNF134 ZNF627 ZSCAN5DP MAZ ZNF202 ZNF322 ZNF233 ZKSCAN2 MYNN ZBTB26 ZNF112 ZNF236 ADNP ZNF529 GFI1 ZNF568 ZFY ZNF710 ZNF462 ZNF599 ZBTB46 ZNF836 ZNF846 ZFP64 ZBTB10 ZNF770 ZSCAN2 ZNF841 ZNF543 ZNF583 ZNF443 ZNF292 | 2.41e-22 | 693 | 103 | 33 | PF00096 |
| Domain | zf-C2H2_6 | ZNF567 ZNF627 MYNN ZNF236 GFI1 ZNF568 ZNF710 ZNF836 ZNF846 ZFP64 ZNF770 ZSCAN2 ZNF841 ZNF543 ZNF443 | 1.87e-10 | 314 | 103 | 15 | PF13912 |
| Domain | KRAB | ZNF567 ZNF627 ZNF202 ZNF233 ZKSCAN2 ZNF112 ZNF529 ZNF568 ZNF599 ZNF836 ZNF846 ZNF543 ZNF583 ZNF443 | 1.03e-08 | 358 | 103 | 14 | PS50805 |
| Domain | KRAB | ZNF567 ZNF627 ZNF202 ZNF233 ZKSCAN2 ZNF112 ZNF529 ZNF568 ZNF599 ZNF836 ZNF846 ZNF543 ZNF583 ZNF443 | 1.03e-08 | 358 | 103 | 14 | PF01352 |
| Domain | KRAB | ZNF567 ZNF627 ZNF202 ZNF233 ZKSCAN2 ZNF112 ZNF529 ZNF568 ZNF599 ZNF836 ZNF846 ZNF543 ZNF583 ZNF443 | 1.51e-08 | 369 | 103 | 14 | SM00349 |
| Domain | KRAB | ZNF567 ZNF627 ZNF202 ZNF233 ZKSCAN2 ZNF112 ZNF529 ZNF568 ZNF599 ZNF836 ZNF846 ZNF543 ZNF583 ZNF443 | 1.57e-08 | 370 | 103 | 14 | IPR001909 |
| Domain | InsP3_rcpt-bd | 1.63e-07 | 3 | 103 | 3 | IPR000493 | |
| Domain | Znf_RING | CBLL1 UBR2 PCGF2 MYCBP2 DTX3 CHD3 CHD4 KMT2C SHPRH NFXL1 NSMCE1 | 1.85e-06 | 326 | 103 | 11 | IPR001841 |
| Domain | RIH_assoc | 3.22e-06 | 6 | 103 | 3 | PF08454 | |
| Domain | RIH_assoc-dom | 3.22e-06 | 6 | 103 | 3 | IPR013662 | |
| Domain | RIH_dom | 3.22e-06 | 6 | 103 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 3.22e-06 | 6 | 103 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 3.22e-06 | 6 | 103 | 3 | IPR015925 | |
| Domain | - | 3.22e-06 | 6 | 103 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 3.22e-06 | 6 | 103 | 3 | PF01365 | |
| Domain | Ins145_P3_rec | 3.22e-06 | 6 | 103 | 3 | PF08709 | |
| Domain | MIR | 1.90e-05 | 10 | 103 | 3 | PS50919 | |
| Domain | MIR | 1.90e-05 | 10 | 103 | 3 | PF02815 | |
| Domain | MIR | 1.90e-05 | 10 | 103 | 3 | SM00472 | |
| Domain | MIR_motif | 1.90e-05 | 10 | 103 | 3 | IPR016093 | |
| Domain | - | CBLL1 UBR2 PCGF2 MYCBP2 DTX3 CHD3 CHD4 ZFYVE28 KMT2C SHPRH RUFY4 | 3.75e-05 | 449 | 103 | 11 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | CBLL1 UBR2 PCGF2 MYCBP2 DTX3 CHD3 CHD4 ZFYVE28 KMT2C SHPRH RUFY4 | 4.58e-05 | 459 | 103 | 11 | IPR013083 |
| Domain | RING | 4.81e-05 | 305 | 103 | 9 | SM00184 | |
| Domain | CHDCT2 | 9.00e-05 | 3 | 103 | 2 | PF08074 | |
| Domain | CHDNT | 9.00e-05 | 3 | 103 | 2 | PF08073 | |
| Domain | DUF1086 | 9.00e-05 | 3 | 103 | 2 | IPR009462 | |
| Domain | DUF1087 | 9.00e-05 | 3 | 103 | 2 | IPR009463 | |
| Domain | CHD_N | 9.00e-05 | 3 | 103 | 2 | IPR012958 | |
| Domain | CHD_C2 | 9.00e-05 | 3 | 103 | 2 | IPR012957 | |
| Domain | DUF1087 | 9.00e-05 | 3 | 103 | 2 | PF06465 | |
| Domain | DUF1086 | 9.00e-05 | 3 | 103 | 2 | PF06461 | |
| Domain | DUF1087 | 9.00e-05 | 3 | 103 | 2 | SM01147 | |
| Domain | DUF1086 | 9.00e-05 | 3 | 103 | 2 | SM01146 | |
| Domain | Znf_FYVE_PHD | 1.64e-04 | 147 | 103 | 6 | IPR011011 | |
| Domain | DUF4195 | 1.79e-04 | 4 | 103 | 2 | PF13836 | |
| Domain | DUF4195 | 1.79e-04 | 4 | 103 | 2 | IPR025243 | |
| Domain | ZF_RING_2 | 2.45e-04 | 298 | 103 | 8 | PS50089 | |
| Domain | SCAN_BOX | 2.94e-04 | 58 | 103 | 4 | PS50804 | |
| Domain | SCAN | 2.94e-04 | 58 | 103 | 4 | PF02023 | |
| Domain | SCAN_dom | 2.94e-04 | 58 | 103 | 4 | IPR003309 | |
| Domain | Defensin_propep | 2.98e-04 | 5 | 103 | 2 | PF00879 | |
| Domain | Alpha-defensin | 2.98e-04 | 5 | 103 | 2 | IPR006081 | |
| Domain | PKNOX/Meis_N | 2.98e-04 | 5 | 103 | 2 | IPR032453 | |
| Domain | Defensin_1 | 2.98e-04 | 5 | 103 | 2 | PF00323 | |
| Domain | Alpha-defensin_pro | 2.98e-04 | 5 | 103 | 2 | IPR016327 | |
| Domain | Meis_PKNOX_N | 2.98e-04 | 5 | 103 | 2 | PF16493 | |
| Domain | DEFENSIN | 2.98e-04 | 5 | 103 | 2 | PS00269 | |
| Domain | Defensin_propep | 2.98e-04 | 5 | 103 | 2 | IPR002366 | |
| Domain | C2H2_Znf_fam | 3.03e-04 | 24 | 103 | 3 | IPR027775 | |
| Domain | Retrov_capsid_C | 3.15e-04 | 59 | 103 | 4 | IPR008916 | |
| Domain | GLYPICAN | 4.45e-04 | 6 | 103 | 2 | PS01207 | |
| Domain | Glypican | 4.45e-04 | 6 | 103 | 2 | IPR001863 | |
| Domain | Glypican | 4.45e-04 | 6 | 103 | 2 | PF01153 | |
| Domain | Glypican_CS | 4.45e-04 | 6 | 103 | 2 | IPR019803 | |
| Domain | Zinc_finger_PHD-type_CS | 4.56e-04 | 65 | 103 | 4 | IPR019786 | |
| Domain | Hematopoietin_rcpt_Gp130_CS | 6.21e-04 | 7 | 103 | 2 | IPR003529 | |
| Domain | SNF2_N | 7.19e-04 | 32 | 103 | 3 | IPR000330 | |
| Domain | SNF2_N | 7.19e-04 | 32 | 103 | 3 | PF00176 | |
| Domain | Defensin_beta/alpha | 8.25e-04 | 8 | 103 | 2 | IPR006080 | |
| Domain | HEMATOPO_REC_L_F2 | 8.25e-04 | 8 | 103 | 2 | PS01353 | |
| Domain | DEFSN | 8.25e-04 | 8 | 103 | 2 | SM00048 | |
| Domain | UBIQUITIN_1 | 1.10e-03 | 37 | 103 | 3 | PS00299 | |
| Domain | ZF_RING_1 | 1.15e-03 | 291 | 103 | 7 | PS00518 | |
| Domain | PHD | 1.49e-03 | 89 | 103 | 4 | SM00249 | |
| Domain | Znf_PHD | 1.61e-03 | 91 | 103 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.89e-03 | 95 | 103 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 1.96e-03 | 96 | 103 | 4 | PS01359 | |
| Domain | zf-H2C2_2 | 2.62e-03 | 14 | 103 | 2 | PF13465 | |
| Domain | UBIQUITIN_2 | 3.29e-03 | 54 | 103 | 3 | PS50053 | |
| Domain | SCAN | 3.65e-03 | 56 | 103 | 3 | SM00431 | |
| Domain | Homeobox_KN | 3.88e-03 | 17 | 103 | 2 | PF05920 | |
| Domain | Homeobox_KN_domain | 3.88e-03 | 17 | 103 | 2 | IPR008422 | |
| Domain | Ubiquitin_dom | 4.03e-03 | 58 | 103 | 3 | IPR000626 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 1.32e-06 | 5 | 73 | 3 | M49000 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 2.64e-06 | 6 | 73 | 3 | M47960 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.09e-05 | 9 | 73 | 3 | M47852 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.56e-05 | 10 | 73 | 3 | M47661 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.13e-05 | 11 | 73 | 3 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 2.13e-05 | 11 | 73 | 3 | M27466 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 3.02e-05 | 70 | 73 | 5 | M8232 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 3.67e-05 | 13 | 73 | 3 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.67e-05 | 13 | 73 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 3.67e-05 | 13 | 73 | 3 | M47751 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 3.67e-05 | 13 | 73 | 3 | MM14553 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 7.11e-05 | 16 | 73 | 3 | M26945 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 1.22e-04 | 19 | 73 | 3 | M27423 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.22e-04 | 19 | 73 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.22e-04 | 19 | 73 | 3 | M47733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 1.43e-04 | 20 | 73 | 3 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 1.66e-04 | 21 | 73 | 3 | M47689 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF567 ZNF627 PCGF2 ZNF202 ZNF233 CHD3 CHD4 ZNF112 ZNF529 ZNF568 ZNF710 ZNF599 KMT2C UBA52 ZNF770 ZNF543 ZNF583 ZNF443 | 1.90e-04 | 1387 | 73 | 18 | M734 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.91e-04 | 22 | 73 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.91e-04 | 22 | 73 | 3 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.19e-04 | 23 | 73 | 3 | M47676 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 2.82e-04 | 25 | 73 | 3 | MM14511 | |
| Pathway | REACTOME_CA2_PATHWAY | 2.94e-04 | 62 | 73 | 4 | M27321 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 3.56e-04 | 27 | 73 | 3 | MM15053 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 3.56e-04 | 27 | 73 | 3 | M12123 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 3.98e-04 | 28 | 73 | 3 | M924 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 4.69e-04 | 70 | 73 | 4 | M3115 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 5.79e-04 | 74 | 73 | 4 | MM15962 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 5.93e-04 | 32 | 73 | 3 | MM14983 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 6.41e-04 | 76 | 73 | 4 | MM15051 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 8.41e-04 | 36 | 73 | 3 | M1315 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 8.41e-04 | 36 | 73 | 3 | M39831 | |
| Pathway | WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY | 9.12e-04 | 37 | 73 | 3 | M42558 | |
| Pathway | REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS | 9.30e-04 | 9 | 73 | 2 | M27781 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 9.49e-04 | 146 | 73 | 5 | M27288 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.02e-03 | 86 | 73 | 4 | M916 | |
| Pathway | REACTOME_CGMP_EFFECTS | 1.16e-03 | 10 | 73 | 2 | MM15054 | |
| Pathway | REACTOME_ALPHA_DEFENSINS | 1.16e-03 | 10 | 73 | 2 | M26955 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 1.23e-03 | 41 | 73 | 3 | M512 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 1.32e-03 | 42 | 73 | 3 | M791 | |
| Pathway | REACTOME_REGULATION_OF_TBK1_IKK_MEDIATED_ACTIVATION_OF_IRF3_IRF7_UPON_TLR3_LIGATION | 1.41e-03 | 11 | 73 | 2 | M48241 | |
| Pathway | REACTOME_ALPHA_DEFENSINS | 1.41e-03 | 11 | 73 | 2 | MM14569 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 1.52e-03 | 44 | 73 | 3 | M39845 | |
| Pathway | SIG_CHEMOTAXIS | 1.62e-03 | 45 | 73 | 3 | M5193 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.62e-03 | 45 | 73 | 3 | MM15344 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 1.72e-03 | 46 | 73 | 3 | M8626 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_SIGNALING | 1.78e-03 | 100 | 73 | 4 | M27467 | |
| Pathway | WP_RETT_SYNDROME | 1.95e-03 | 48 | 73 | 3 | M39759 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.95e-03 | 48 | 73 | 3 | M27642 | |
| Pathway | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | 1.99e-03 | 13 | 73 | 2 | MM15015 | |
| Pathway | REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA | 1.99e-03 | 13 | 73 | 2 | MM14931 | |
| Pathway | REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7 | 1.99e-03 | 13 | 73 | 2 | M27884 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 2.19e-03 | 50 | 73 | 3 | M47951 | |
| Pathway | REACTOME_REGULATION_OF_TBK1_IKK_IKBKE_MEDIATED_ACTIVATION_OF_IRF3_IRF7 | 2.31e-03 | 14 | 73 | 2 | M48239 | |
| Pathway | REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2 | 2.31e-03 | 14 | 73 | 2 | M27263 | |
| Pathway | REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING | 2.31e-03 | 14 | 73 | 2 | MM15642 | |
| Pubmed | ZEB1 ZSCAN5DP ZNF280C ZNF202 ZNF322 ZNF280B CHD3 MYNN ZNF236 MEIS2 ZNF710 ZNF462 ZBTB46 ZNF836 MBNL2 ZFP64 ZNF292 NPAS2 | 4.60e-11 | 808 | 106 | 18 | 20412781 | |
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 4.99e-09 | 125 | 106 | 8 | 32891193 | |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 10874040 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 9808793 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 20395455 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 17437169 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 18194433 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 18547250 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 36350267 | ||
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 2.75e-08 | 3 | 106 | 3 | 27777977 | |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 11413485 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 26009177 | ||
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 2.75e-08 | 3 | 106 | 3 | 17581770 | |
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 2.75e-08 | 3 | 106 | 3 | 18241669 | |
| Pubmed | Receptor-activated single channels in intact human platelets. | 2.75e-08 | 3 | 106 | 3 | 1693919 | |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 19068129 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 23955339 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 31979185 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 2.75e-08 | 3 | 106 | 3 | 24904548 | |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 17327232 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 16014380 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 17890015 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 2.75e-08 | 3 | 106 | 3 | 23983250 | |
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 2.75e-08 | 3 | 106 | 3 | 9858485 | |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 20427533 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZNF567 MAZ ZNF280C CHD3 CHD4 ADNP ZNF462 SHPRH ZBTB10 ZNF770 USP48 NSMCE1 ZNF292 | 4.52e-08 | 608 | 106 | 13 | 36089195 |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | ZNF567 DENND4A PCGF2 ZNF202 CHD4 MYNN MEIS3 ZNF236 GFI1 MEIS2 ZFY ZFP64 ZSCAN2 ZNF292 NPAS2 | 7.24e-08 | 877 | 106 | 15 | 20211142 |
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 25215520 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B. | 1.10e-07 | 4 | 106 | 3 | 21424589 | |
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 28615414 | ||
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 10828023 | ||
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 28419336 | ||
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 11163362 | ||
| Pubmed | IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming. | 1.10e-07 | 4 | 106 | 3 | 35494252 | |
| Pubmed | InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences. | 2.74e-07 | 5 | 106 | 3 | 21568942 | |
| Pubmed | 5.47e-07 | 6 | 106 | 3 | 23463619 | ||
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 5.47e-07 | 6 | 106 | 3 | 21762810 | |
| Pubmed | 5.47e-07 | 6 | 106 | 3 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 5.47e-07 | 6 | 106 | 3 | 25966694 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 5.47e-07 | 6 | 106 | 3 | 16844763 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | ZEB1 MAZ ZNF202 ZNF322 ZKSCAN2 MEIS3 ZNF236 ADNP MEIS2 ZFY SKOR1 NFXL1 ZSCAN2 NPAS2 | 7.08e-07 | 908 | 106 | 14 | 19274049 |
| Pubmed | 9.55e-07 | 7 | 106 | 3 | 11860456 | ||
| Pubmed | Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. | 9.55e-07 | 7 | 106 | 3 | 22495310 | |
| Pubmed | 2.28e-06 | 9 | 106 | 3 | 25737585 | ||
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | PCGF2 MYCBP2 ZNF280C CHD3 CHD4 ADNP ZNF462 KMT2C LAS1L ZNF292 | 2.93e-06 | 495 | 106 | 10 | 27705803 |
| Pubmed | 3.26e-06 | 74 | 106 | 5 | 29795351 | ||
| Pubmed | Type 1 and 3 inositol trisphosphate receptors are required for extra-embryonic vascular development. | 4.46e-06 | 11 | 106 | 3 | 27514653 | |
| Pubmed | 5.64e-06 | 418 | 106 | 9 | 34709266 | ||
| Pubmed | PDE2A PCGF2 MYO1E MYCBP2 ZNF202 CHD4 MYNN ZNF836 ACAD8 SACS LRP1 ZNF841 ZNF583 SF3A2 ZNF292 | 8.36e-06 | 1285 | 106 | 15 | 35914814 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 8.51e-06 | 440 | 106 | 9 | 34244565 | |
| Pubmed | Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. | 9.20e-06 | 2 | 106 | 2 | 12871849 | |
| Pubmed | Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. | 9.20e-06 | 2 | 106 | 2 | 7560064 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 16837860 | ||
| Pubmed | Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin. | 9.20e-06 | 2 | 106 | 2 | 9065779 | |
| Pubmed | Expression of IP3 receptor isoforms at the nodes of Ranvier in rat sciatic nerve. | 9.20e-06 | 2 | 106 | 2 | 17496801 | |
| Pubmed | Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor. | 9.20e-06 | 2 | 106 | 2 | 8663526 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15208269 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15890645 | ||
| Pubmed | Plasma human neutrophil proteins-1, -2, and -3 levels in patients with bladder cancer. | 9.20e-06 | 2 | 106 | 2 | 23011762 | |
| Pubmed | Mice lacking inositol 1,4,5-trisphosphate receptors exhibit dry eye. | 9.20e-06 | 2 | 106 | 2 | 24901844 | |
| Pubmed | Human Neutrophil Peptides 1-3--early markers in development of colorectal adenomas and carcinomas. | 9.20e-06 | 2 | 106 | 2 | 18957723 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20880148 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 33854148 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20195543 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18708078 | ||
| Pubmed | Salivary levels of HNP 1-3 are related to oral ulcer activity in Behçet's disease. | 9.20e-06 | 2 | 106 | 2 | 22861387 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15201137 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19528657 | ||
| Pubmed | The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas. | 9.20e-06 | 2 | 106 | 2 | 37870961 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 8063813 | ||
| Pubmed | Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. | 9.20e-06 | 2 | 106 | 2 | 8081734 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20424487 | ||
| Pubmed | Defensins: antimicrobial and cytotoxic peptides of mammalian cells. | 9.20e-06 | 2 | 106 | 2 | 8476558 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 7575689 | ||
| Pubmed | Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. | 9.20e-06 | 2 | 106 | 2 | 23582047 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 1374893 | ||
| Pubmed | Detection of colorectal disease by stool defensin assay: an exploratory study. | 9.20e-06 | 2 | 106 | 2 | 17531545 | |
| Pubmed | IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. | 9.20e-06 | 2 | 106 | 2 | 16195467 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 29950924 | ||
| Pubmed | Increased levels of human neutrophil alpha-defensins in chronic venous leg ulcers. | 9.20e-06 | 2 | 106 | 2 | 18472248 | |
| Pubmed | Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. | 9.20e-06 | 2 | 106 | 2 | 2006422 | |
| Pubmed | Localization of human neutrophil peptide (HNP) and its messenger RNA in neutrophil series. | 9.20e-06 | 2 | 106 | 2 | 8080882 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15632133 | ||
| Pubmed | The capsule sensitizes Streptococcus pneumoniae to alpha-defensins human neutrophil proteins 1 to 3. | 9.20e-06 | 2 | 106 | 2 | 18474654 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20813840 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15713744 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 7559486 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19864642 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21333105 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20843799 | ||
| Pubmed | Increased levels of alpha-defensin (-1, -2 and -3) in type 1 diabetic patients with nephropathy. | 9.20e-06 | 2 | 106 | 2 | 18003664 | |
| Pubmed | Type 1 and 2 IP3 receptors respond differently to catecholamines and stress. | 9.20e-06 | 2 | 106 | 2 | 19120126 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22297599 | ||
| Pubmed | Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development. | 9.20e-06 | 2 | 106 | 2 | 35568926 | |
| Pubmed | Identification of recurrent USP48 and BRAF mutations in Cushing's disease. | 9.20e-06 | 2 | 106 | 2 | 30093687 | |
| Pubmed | Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen. | 9.20e-06 | 2 | 106 | 2 | 8843877 | |
| Pubmed | Alpha-defensin overexpression in patients with Bell's palsy and Ramsay Hunt syndrome. | 9.20e-06 | 2 | 106 | 2 | 22737966 | |
| Pubmed | Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery. | 9.20e-06 | 2 | 106 | 2 | 18757648 | |
| Pubmed | Distinct roles of inositol 1,4,5-trisphosphate receptor types 1 and 3 in Ca2+ signaling. | 9.20e-06 | 2 | 106 | 2 | 14707143 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25300997 | ||
| Interaction | RASEF interactions | 7.21e-06 | 25 | 102 | 4 | int:RASEF | |
| Interaction | ZMYM2 interactions | 9.69e-06 | 271 | 102 | 9 | int:ZMYM2 | |
| Interaction | NOTCH2 interactions | ZNF627 DTX3 MAZ ZKSCAN2 MYNN UBA52 ZFP64 ZNF888 ZSCAN2 TOP3B NPNT | 9.83e-06 | 423 | 102 | 11 | int:NOTCH2 |
| Interaction | BBOX1 interactions | 1.33e-05 | 29 | 102 | 4 | int:BBOX1 | |
| Interaction | MYNN interactions | 1.99e-05 | 32 | 102 | 4 | int:MYNN | |
| Interaction | L3MBTL2 interactions | 2.29e-05 | 231 | 102 | 8 | int:L3MBTL2 | |
| Interaction | H3-3A interactions | ZNF567 MAZ ZNF280C CHD3 CHD4 ADNP KMT2C UBA52 SHPRH ZBTB10 ZNF770 USP48 TOP3B ZNF292 | 2.45e-05 | 749 | 102 | 14 | int:H3-3A |
| Interaction | IRAG1 interactions | 4.40e-05 | 14 | 102 | 3 | int:IRAG1 | |
| Interaction | TESPA1 interactions | 6.72e-05 | 16 | 102 | 3 | int:TESPA1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF567 ZNF134 ZSCAN5DP ZNF233 MEIS3 ZNF112 ZNF529 ZNF568 ZNF599 ZNF836 ZNF888 ZNF841 ZNF543 ZNF583 | 5.99e-07 | 1192 | 105 | 14 | chr19q13 |
| Cytoband | Xq26.1 | 6.09e-04 | 16 | 105 | 2 | Xq26.1 | |
| Cytoband | 19q13.41 | 7.81e-04 | 78 | 105 | 3 | 19q13.41 | |
| Cytoband | 19q13.43 | 1.07e-03 | 87 | 105 | 3 | 19q13.43 | |
| Cytoband | 22q11.22 | 1.27e-03 | 23 | 105 | 2 | 22q11.22 | |
| Cytoband | 16p12.1 | 1.50e-03 | 25 | 105 | 2 | 16p12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p12 | 2.27e-03 | 113 | 105 | 3 | chr12p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 2.43e-03 | 797 | 105 | 7 | chr19p13 | |
| Cytoband | 12p12.3 | 2.46e-03 | 32 | 105 | 2 | 12p12.3 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF567 ZNF134 ZNF627 ZEB1 ZSCAN5DP MAZ ZNF202 ZNF322 ZNF233 ZKSCAN2 MYNN ZBTB26 ZNF112 ZNF236 ZNF529 GFI1 ZNF568 ZFY ZNF710 ZNF462 ZNF599 ZBTB46 ZNF836 ZNF846 ZFP64 ZBTB10 ZNF888 ZNF770 ZSCAN2 ZNF841 ZNF543 ZNF583 ZNF443 ZNF292 | 3.86e-25 | 718 | 88 | 34 | 28 |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 1.11e-07 | 3 | 88 | 3 | 297 | |
| GeneFamily | Glypicans | 3.47e-04 | 6 | 88 | 2 | 572 | |
| GeneFamily | PHD finger proteins | 9.73e-04 | 90 | 88 | 4 | 88 | |
| GeneFamily | Defensins, alpha | 1.50e-03 | 12 | 88 | 2 | 502 | |
| GeneFamily | PHD finger proteins|NuRD complex | 1.50e-03 | 12 | 88 | 2 | 1305 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.36e-03 | 15 | 88 | 2 | 529 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 4.16e-03 | 134 | 88 | 4 | 861 | |
| GeneFamily | TALE class homeoboxes and pseudogenes | 7.06e-03 | 26 | 88 | 2 | 526 | |
| Coexpression | OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP | 9.92e-06 | 349 | 103 | 9 | M283 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_3|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.94e-07 | 192 | 106 | 7 | d88753b200d9c8da6716222d697ddf0a1548d6c8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.23e-07 | 194 | 106 | 7 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | 3'_v3-Lung-Myeloid_Monocytic-Cycling_mono|Lung / Manually curated celltypes from each tissue | 4.33e-06 | 178 | 106 | 6 | 67aa17b17da3121c199af45e747c23e2626a9bb2 | |
| ToppCell | CTRL-Myeloid-cDC|CTRL / Disease state, Lineage and Cell class | 5.08e-06 | 183 | 106 | 6 | 20c4d16de7e090df3556a4458f783383a26871b6 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.49e-06 | 191 | 106 | 6 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.69e-06 | 192 | 106 | 6 | 446c61c0d6ba89c619efe87ee495951299953981 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.89e-06 | 193 | 106 | 6 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.30e-06 | 195 | 106 | 6 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.29e-05 | 126 | 106 | 5 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | COVID-CD4-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 3.93e-05 | 159 | 106 | 5 | 037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 163 | 106 | 5 | a24db9d266a40f3bffe4f18d277bc269791b4560 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.11e-05 | 168 | 106 | 5 | 2fb2d916eb5000a637240d38e47a9b4f61f9f83f | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 6.90e-05 | 179 | 106 | 5 | 5f7e6670a0e906a0a5bc75735408361d88e78fa2 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 7.47e-05 | 182 | 106 | 5 | 0e8cfbd8ea196f27a227dbb4d2eb93bc48d27922 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 183 | 106 | 5 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 183 | 106 | 5 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | IPF-Myeloid-DC_Langerhans|IPF / Disease state, Lineage and Cell class | 8.06e-05 | 185 | 106 | 5 | f8ee3cb2aa9ec70f9ce8797be2b155da27ef6464 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.06e-05 | 185 | 106 | 5 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 8.06e-05 | 185 | 106 | 5 | ced17f69486591c3cbbdc852a3e82c3f3a4a30d7 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.27e-05 | 186 | 106 | 5 | a558fd00053e7dd6216b01dc8e650c30cee451f1 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.27e-05 | 186 | 106 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.27e-05 | 186 | 106 | 5 | 75b1f342be5d6dbe0e7acd924a0ca75964f6bab0 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.27e-05 | 186 | 106 | 5 | 0c3d195077de7b4c354c127a26116438aef29244 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 8.27e-05 | 186 | 106 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.48e-05 | 187 | 106 | 5 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.92e-05 | 189 | 106 | 5 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 8.92e-05 | 189 | 106 | 5 | 3717d1148e26ac78a26aea0ca1dbfbb9d3668877 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.37e-05 | 191 | 106 | 5 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.60e-05 | 192 | 106 | 5 | aee6522d25e012231cdb905ce047295cb64d6e82 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.84e-05 | 193 | 106 | 5 | ac227ddabfb3f021b1b39dba73f898517cd5a58e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.84e-05 | 193 | 106 | 5 | f4135615ee0118eec9e221becdd67888e0c2a112 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 194 | 106 | 5 | fa6d51f36a3dae8763a595c20892987ed454c0f0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-04 | 195 | 106 | 5 | 0c49d22c348aec6d8a1a976e7c88d0a3b48a4244 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.08e-04 | 197 | 106 | 5 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.08e-04 | 197 | 106 | 5 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.08e-04 | 197 | 106 | 5 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 198 | 106 | 5 | b027a141ab531d0f5d6a26811a53427e7b0771dd | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-04 | 199 | 106 | 5 | 4217b9e66c5374461e84bdb893ab650f148286c8 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| Drug | LG 5 | 7.00e-06 | 60 | 101 | 5 | CID011840957 | |
| Drug | 2-methoxyethoxy)acetic acid | 1.95e-05 | 2 | 101 | 2 | CID000027642 | |
| Drug | p-sulfobenzyl alcohol | 1.95e-05 | 2 | 101 | 2 | CID000441138 | |
| Drug | adenophostin A | 1.95e-05 | 2 | 101 | 2 | ctd:C085029 | |
| Drug | Isocaffeine | 1.95e-05 | 2 | 101 | 2 | CID000001326 | |
| Drug | adenophostin B | 1.95e-05 | 2 | 101 | 2 | CID000656722 | |
| Drug | 1,2,5,6-tetramethylnaphthalene | 1.95e-05 | 2 | 101 | 2 | CID006427081 | |
| Drug | benzene 1,2,4-trisphosphate | 1.95e-05 | 2 | 101 | 2 | CID000192376 | |
| Drug | 1,4,5-trimethylnaphthalene | 1.95e-05 | 2 | 101 | 2 | CID000016478 | |
| Disease | Sezary Syndrome | 2.14e-06 | 27 | 101 | 4 | C0036920 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 8.37e-06 | 12 | 101 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | Anoxic Encephalopathy | 1.16e-05 | 2 | 101 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 1.16e-05 | 2 | 101 | 2 | C1527348 | |
| Disease | Anoxia of brain | 1.16e-05 | 2 | 101 | 2 | C0995195 | |
| Disease | Hypoxic Brain Damage | 1.16e-05 | 2 | 101 | 2 | C1140716 | |
| Disease | Neurodevelopmental Disorders | 1.74e-05 | 93 | 101 | 5 | C1535926 | |
| Disease | severe congenital neutropenia (implicated_via_orthology) | 3.47e-05 | 3 | 101 | 2 | DOID:0050590 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 1.54e-04 | 447 | 101 | 8 | C3714756 | |
| Disease | parenchymal hematoma, response to recombinant tissue-plasminogen activator | 1.72e-04 | 6 | 101 | 2 | EFO_0020101, EFO_0600080 | |
| Disease | Abnormality of the skeletal system | 3.20e-04 | 8 | 101 | 2 | C4021790 | |
| Disease | restless legs syndrome (implicated_via_orthology) | 3.20e-04 | 8 | 101 | 2 | DOID:0050425 (implicated_via_orthology) | |
| Disease | interleukin 1 receptor-like 1 measurement | 6.25e-04 | 11 | 101 | 2 | EFO_0008168 | |
| Disease | Congenital neutropenia | 7.49e-04 | 12 | 101 | 2 | C0340970 | |
| Disease | neutrophil count, eosinophil count | 8.45e-04 | 213 | 101 | 5 | EFO_0004833, EFO_0004842 | |
| Disease | prostate carcinoma | ZNF322 IP6K1 ZNF280B CHD3 ZNF112 ZNF236 ADNP ZBTB46 GPC5 GNAO1 | 9.67e-04 | 891 | 101 | 10 | EFO_0001663 |
| Disease | multiple sclerosis | 1.01e-03 | 594 | 101 | 8 | MONDO_0005301 | |
| Disease | Cardiovascular Abnormalities | 1.35e-03 | 16 | 101 | 2 | C0243050 | |
| Disease | amyotrophic lateral sclerosis | 1.58e-03 | 145 | 101 | 4 | MONDO_0004976 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 1.91e-03 | 19 | 101 | 2 | C3501846 | |
| Disease | Costello syndrome (disorder) | 1.91e-03 | 19 | 101 | 2 | C0587248 | |
| Disease | age at onset, smoking initiation | 1.91e-03 | 19 | 101 | 2 | EFO_0004847, EFO_0005670 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 1.91e-03 | 19 | 101 | 2 | C1843181 | |
| Disease | leukemia (implicated_via_orthology) | 1.91e-03 | 19 | 101 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | angiopoietin-1 receptor measurement | 1.91e-03 | 19 | 101 | 2 | EFO_0010600 | |
| Disease | Cardio-facio-cutaneous syndrome | 1.91e-03 | 19 | 101 | 2 | C1275081 | |
| Disease | myelodysplastic syndrome (is_marker_for) | 2.12e-03 | 20 | 101 | 2 | DOID:0050908 (is_marker_for) | |
| Disease | granulocyte percentage of myeloid white cells | 2.32e-03 | 268 | 101 | 5 | EFO_0007997 | |
| Disease | nose morphology measurement, mouth morphology measurement | 2.33e-03 | 21 | 101 | 2 | EFO_0007843, EFO_0007955 | |
| Disease | Granulomatous Slack Skin | 2.56e-03 | 22 | 101 | 2 | C0376407 | |
| Disease | LEOPARD Syndrome | 2.56e-03 | 22 | 101 | 2 | C0175704 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 2.80e-03 | 23 | 101 | 2 | C0079773 | |
| Disease | Carcinoma of lung | 2.80e-03 | 23 | 101 | 2 | C0684249 | |
| Disease | Colorectal Carcinoma | 2.86e-03 | 702 | 101 | 8 | C0009402 | |
| Disease | Noonan Syndrome | 3.05e-03 | 24 | 101 | 2 | C0028326 | |
| Disease | diet measurement | ZNF322 ZKSCAN2 ITPR1 KIRREL3 ZBTB46 ZNF770 GPC5 GNAO1 CAPZA3 MAFIP | 3.20e-03 | 1049 | 101 | 10 | EFO_0008111 |
| Disease | chronotype measurement | 3.30e-03 | 882 | 101 | 9 | EFO_0008328 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FCLKIFKTATPYMCH | 436 | Q86YH2 | |
| DHYPKGNCNMLRKTV | 131 | Q96KX2 | |
| IHCKRCLFMPKSYEA | 221 | Q9H2P0 | |
| YKFHQRCSTEVPLMC | 266 | P15056 | |
| QRHKFCPPLCTMEKF | 141 | Q9UKU7 | |
| FVCHCQLGYMVRKGA | 1261 | Q75N90 | |
| EHCNKYSKIPRHCMS | 1696 | Q7Z401 | |
| RMCAVFGGIYCLRHK | 391 | P26374 | |
| LPYLGPHKMRDCFCT | 51 | Q15283 | |
| CLFKVCPMNRYSAQK | 56 | Q14571 | |
| KFRDCLFKVCPMNRY | 51 | Q14573 | |
| GQVKPVRVCTHCYMF | 861 | Q9HCC9 | |
| QHLMQFGKGKSCCYR | 301 | Q99743 | |
| GIICLDCKLHTPMYF | 46 | Q96R47 | |
| KGYHTFCLQPVMKSV | 411 | Q8NEZ4 | |
| FIDRQKCMAHRTCYP | 101 | Q8WZ33 | |
| KCMAHRTCYPTILQL | 106 | Q8WZ33 | |
| CGKHTKRMPCHKPYL | 451 | Q6ZNB6 | |
| KRMPCHKPYLCETKC | 456 | Q6ZNB6 | |
| PCQYCGKRFHQKSDM | 341 | Q99684 | |
| KPRPCKHRCMNTYGS | 96 | Q6UXI9 | |
| CLFKLCPMNRYSAQK | 56 | Q14643 | |
| MIYCSHCRGLVTVKP | 251 | O75487 | |
| KECSRALLKMQYCPH | 246 | P78333 | |
| NYNRTVSCACPHLMK | 1556 | Q07954 | |
| FCHRYISCLKGKMPI | 171 | O14770 | |
| YPVAGNMAKHFCKVL | 151 | P06126 | |
| CTRCMKGYFIAPTNH | 1001 | Q92824 | |
| CPTLARFCLMVKKGY | 636 | O00408 | |
| MRIHKGVKPYVCHLC | 321 | Q9NPC7 | |
| KVPCHVCGKMLSSAY | 391 | P56270 | |
| NFCHRYITCLKGKMP | 156 | Q99687 | |
| KKMPHINDCRRGCYF | 161 | Q9Y4W2 | |
| CDKMICRKCYARLHP | 91 | P62987 | |
| IKIYGRMIPCKHVFC | 116 | Q75N03 | |
| KYCPMCDVQVHKTRP | 51 | P35227 | |
| KKACPMCGRFYGQLV | 196 | Q8N9I9 | |
| KHPGSRKNMACYCRI | 56 | P59665 | |
| KHPGSRKNMDCYCRI | 56 | P59666 | |
| HTMPRRKKGYCECCQ | 291 | Q8NFT6 | |
| KKCCNHPYLFPVAAM | 1026 | Q12873 | |
| CKLTKLCPAMGYTFR | 436 | Q53EP0 | |
| MRYSCSLPCVKKHKA | 236 | Q9NWK9 | |
| CCIPRKHLLLYQNMG | 186 | Q99062 | |
| TYRLQLHMLSCPCKA | 281 | P42701 | |
| CMREKCKYFHPPAHL | 226 | Q5VZF2 | |
| HFKYPCVLDLKMGTR | 216 | Q92551 | |
| GCCLVLGYMAKDKFR | 26 | Q8IZU9 | |
| YCKMVLHGAKYPHCA | 11 | O43402 | |
| MPYINICGTSNHRKK | 1101 | Q8NDH2 | |
| VVMDLKKCCNHPYLF | 1011 | Q14839 | |
| KKCCNHPYLFPVAAM | 1016 | Q14839 | |
| VCNMIPFCTIKLGYH | 61 | A6NIM6 | |
| NPSKLIMKPIHECCY | 1386 | Q9NZJ4 | |
| KSLYFKLRSMIPCCL | 756 | Q86YS7 | |
| HICGFPIKMTSKPCY | 301 | Q68DL7 | |
| TCGIRMHLPCVAKYF | 206 | Q8WV22 | |
| SHFFCDIRPIMKLAC | 176 | P0C629 | |
| MYVSNCNPCAIHRKI | 1 | Q8NGB2 | |
| KMLTPRHCTGNCSFK | 946 | P84550 | |
| KNRSPNKEIYCHMTC | 311 | P09471 | |
| GGLLCHACSMDYKKR | 541 | Q6ZNE9 | |
| LKIKPFYCPHCLVAM | 696 | Q149N8 | |
| MCPKHGTDFLEYKCR | 4586 | O75592 | |
| MAALYACTKCHQRFP | 1 | Q8TAV0 | |
| KRMVCHSSPGPCYLL | 76 | Q8IXM7 | |
| RLCHNVGYKKMVLPN | 66 | Q8N474 | |
| FMKNHLGSYECKLCL | 46 | Q15428 | |
| EKHPCLYILMFGCVF | 291 | Q8WUD6 | |
| LSRCGKCHRFMKYIQ | 621 | O95985 | |
| SYECPHCGKAFRMKS | 476 | Q8N184 | |
| MRLHTGEKPYKCIEC | 246 | Q96NL3 | |
| TRIHSGKKPYVCMEC | 301 | Q147U1 | |
| QRTHTGEKPYKCLMC | 521 | Q7Z7L9 | |
| KPYTCDICHKRFNRM | 406 | P0CG00 | |
| MRSHTGEKPYKCNKC | 381 | Q3ZCX4 | |
| HRAGCKLVMVLFQYC | 211 | P47872 | |
| VFRAKCMFPKCGRIF | 776 | O60281 | |
| HTGEKPYKCLECMRS | 261 | Q6U7Q0 | |
| PFKCKVCGKSFNRMY | 546 | Q8N1W2 | |
| MLTHRGGVPYKCKVC | 186 | Q7L945 | |
| MIKHTGNGPYKCKVC | 326 | Q7L945 | |
| CPANMCKHKVLSDYL | 171 | Q8TCT1 | |
| RKNIHACTICGKMFP | 156 | Q6IQ21 | |
| MRLHSGEKPYQCDKC | 951 | P37275 | |
| KPLHCNKCGMVFTYY | 451 | Q6ZN19 | |
| KPYKCMECGKAFGRR | 731 | Q6ZN19 | |
| RRCHTGEKPYMCNKC | 261 | P0CJ79 | |
| RVHTRVKPYKCEMCG | 741 | Q9UJU3 | |
| YIIHTGEKPYKCMEC | 386 | Q08ER8 | |
| IHMREKSYECPQCGK | 581 | Q9Y2A4 | |
| QRIHTGEKPYKCGMC | 611 | A6NK53 | |
| RMTHHKENPYKCGVC | 766 | Q63HK3 | |
| CPLCLYHTKYKRNMI | 2256 | Q96JM2 | |
| KHTGERPYKCAYCVM | 1771 | Q9UL36 | |
| FNLLDPLKYHMKHCC | 246 | Q8ND82 | |
| SLIMNKLKCPHCSYV | 716 | Q96DT7 | |
| KPYKCMHCEKVFRIS | 336 | Q6P280 | |
| RVCGKIGHYMKDCPK | 1296 | Q5TAX3 | |
| YKKCLAVLMQCHGGY | 566 | Q8IWV8 | |
| PKCGKGTHCSRNAYM | 401 | Q86UV5 | |
| LRTHTGEKPYKCMEC | 416 | O95125 | |
| KTHMRCHTGVKPYKC | 191 | Q9NTW7 | |
| RSHTGEKPYMCKECR | 456 | Q96ND8 | |
| KRIHTGEMPYKCNEC | 251 | P52741 | |
| CNYCDMVFAHKPVLR | 356 | Q9HCK0 | |
| PYCSFSAMHQCILKR | 421 | Q86UZ6 | |
| HKVLIMEFCPCGSLY | 81 | Q9UHD2 | |
| THIREKPYMCKGCGK | 211 | Q6ZNA1 | |
| HPLTVYPCMICGKKF | 416 | P08048 | |
| LMKCTPHYIRCIKPN | 576 | Q12965 | |
| QLCAMCFSPKKLYKH | 251 | Q9NR99 |